Clinical Trial Update: BIOFLOW-III VIP Russia Registry Orsiro Stent System

View source ↗

Summary

Update on the BIOFLOW-III VIP Russia registry evaluating the Orsiro Stent System for coronary artery disease; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Orsiro Stent System

Snippet

Sponsor: Biotronik Russia | Conditions: Coronary Artery Diseases | Status: UNKNOWN